Literature DB >> 10905633

Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex.

E Francescangeli1, A Boila, G Goracci.   

Abstract

Platelet-activating factor (PAF) is a phospholipid mediator of long-term potentiation, synaptic plasticity and memory formation as well as of the development of brain damage. In brain, PAF is synthesized by two distinct pathways but their relative contribution to its productions, in various physiological and pathological conditions, is not established. We have further investigated on the properties of the two enzymes that catalyze the last step of the de novo or remodeling pathways in rat brain microsomes, PAF-synthesizing phosphocholinetransferase (PAF-PCT) and lysoPAF acetyltransferase (lysoPAF-AT), respectively. The latter enzyme is fully active at microM Ca2+ concentration, inhibited by MgATP and activated by phosphorylation. Because the reversibility of the reaction catalyzed by PAF-PCT, its direction depends on the ratio [CDP-choline]/[CMP], which is related to the energy charge of the cell. These and other properties indicate that the de novo pathway should mainly contribute to PAF synthesis for maintaining its basal levels under physiological conditions. The remodeling pathway should be more involved in the production of PAF during ischemia. During reperfusion, the overproduction of PAF should be the result of the concomitant activation of both pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905633     DOI: 10.1023/a:1007523422825

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  56 in total

1.  Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death.

Authors:  P K Mukherjee; M A DeCoster; F Z Campbell; R J Davis; N G Bazan
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens.

Authors:  T C Lee; B Malone; F Snyder
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  Acetylcholine-induced production of platelet-activating factor by human fetal brain cells in culture.

Authors:  V Sogos; F Bussolino; E Pilia; S Torelli; F Gremo
Journal:  J Neurosci Res       Date:  1990-12       Impact factor: 4.164

4.  The action of brain phospholipases A2 on purified, specifically labelled 1,2-diacyl-, 2-acyl-1-alk-1'-enyl- and 2-acyl-1-alkyl-sn-glycero-3-phosphorylcholine.

Authors:  H Woelk; G Goracci; G Porcellati
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-01

5.  The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.

Authors:  M L Blank; Z L Smith; V Fitzgerald; F Snyder
Journal:  Biochim Biophys Acta       Date:  1995-02-09

6.  Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock.

Authors:  D L Birkle; P Kurian; P Braquet; N G Bazan
Journal:  J Neurochem       Date:  1988-12       Impact factor: 5.372

7.  Long-term potentiation in the hippocampus induced by platelet-activating factor.

Authors:  A Wieraszko; G Li; E Kornecki; M V Hogan; Y H Ehrlich
Journal:  Neuron       Date:  1993-03       Impact factor: 17.173

8.  The effect of CMP on the release of free fatty acids of rat brain in vitro.

Authors:  G Goracci; E Francescangeli; L A Horrocks; G Porcellati
Journal:  Neurochem Res       Date:  1983-08       Impact factor: 3.996

9.  Properties of PAF-synthesizing phosphocholinetransferase and evidence for lysoPAF acetyltransferase activity in rat brain.

Authors:  G Goracci; E Francescangeli
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

10.  Platelet-activating factor in brain regions after transient ischemia in gerbils.

Authors:  K Nishida; S P Markey
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

View more
  6 in total

1.  Down-regulation of platelet-activating factor receptor gene expression during focal reversible cerebral ischemia in rats.

Authors:  Xiong Zhang; Xi-Long Pan; Xin-Tong Liu; Shuo Wang; Li-Juan Wang
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

Review 2.  The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

3.  Activation of PAF-synthesizing enzymes in rat brain stem slices after LTP induction in the medial vestibular nuclei.

Authors:  Ermelinda Francescangeli; Silvarosa Grassi; Vito E Pettorossi; Gianfrancesco Goracci
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

4.  In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.

Authors:  Alexandros B Tsoupras; Maria Chini; Nickolaos Tsogas; Athina Lioni; George Tsekes; Constantinos A Demopoulos; Marios C Lazanas
Journal:  J Inflamm (Lond)       Date:  2011-07-07       Impact factor: 4.981

5.  Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells.

Authors:  Alexandros Basilios Tsoupras; Elizabeth Fragopoulou; Tzortzis Nomikos; Christos Iatrou; Smaragdi Antonopoulou; Constantinos Alexandros Demopoulos
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

6.  Platelet-activating factor (PAF) strongly enhances contractile mechanical activities in guinea pig and mouse urinary bladder.

Authors:  Ge Liu; Mizuki Kaneko; Kento Yoshioka; Keisuke Obara; Yoshio Tanaka
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.